[1] GOPIE P,MEI L,FABER AC,et al.Classification of gastrointestinal stromal tumor syndromes[J].Endocr Relat Cancer,2018,25(2):R49-R58.
[2] AKAHOSHI K,OYA M,KOGA T,et al.Current clinical management of gastrointestinal stromal tumor[J].World J Gastroenterol,2018,24(26):2806-2817.
[3] MCGOUGH IJ,VECCHIA L,BISHOP B,et al.Glypicans shield the Wnt lipid moiety to enable signalling at a distance[J].Nature,2020,585(7823):85-90.
[4] DINCCELIK-ASLAN M,GUMUS-AKAY G,ELHAN AH,et al.Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinoma[J].Mol Clin Oncol,2015,3(3):584-590.
[5] ZOU J,LEI T,GUO P,et al.Mechanisms shaping the role of ERK1/2 in cellular senescence(review)[J].Mol Med Rep,2019,19(2):759-770.
[6] LIU X,WANG G,YAN X,et al.Preclinical development of HQP1351,a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases,for the treatment of imatinib-resistant gastrointestinal stromal tumors[J].Cell Biosci,2019,9:88-101.
[7] JOENSUU H.Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J].Hum Pathol,2008,39(10):1411-1419.
[8] PARAB TM,DEROGATIS MJ,BOAZ AM,et al.Gastrointestinal stromal tumors:a comprehensive review[J].J Gastrointest Oncol,2019,10(1):144-154.
[9] KANDA T.Review gastrointestinal stromal tumors:to prospect the next decade[J].Transl Gastroenterol Hepatol,2018,3:46-55.
[10] STRZYZ P.Glypican shield for WNTs[J].Nat Rev Mol Cell Biol,2020,21(9):499-510.
[11] DONGRE A,WEINBERG RA.New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer[J].Nat Rev Mol Cell Biol,2019,20(2):69-84.
[12] LI Y,LI M,SHATS I,et al.Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma[J].PLoS One,2019,14(6):218-226.
[13] FAN C,TU C,QI P,et al.GPC6 promotes cell proliferation,migration,and invasion in nasopharyngeal carcinoma[J].J Cancer,2019,10(17):3926-3932.
[14] ZENG C,YAN R,YANG G,et al.Hedgehog signaling activation required for glypican-6-mediated regulation of invasion,migration,and epithelial-mesenchymal transition of gastric cancer cells[J].Biosci Rep,2020,40(6):3181-3193.
[15] ROSKOSKI R JR.Targeting ERK1/2 protein-serine/threonine kinases in human cancers[J].Pharmacol Res,2019,142:151-168.
[16] MONTAGNANI V,MARESCA L,APOLLO A,et al.E3 ubiquitin ligase PARK2,an inhibitor of melanoma cell growth,is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis[J].J Biol Chem,2020,16:146-159.
[17] YANG YF,CHANG YC,JAN YH,et al.Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway[J].Oncogenesis,2020,9(8):78-89.
[18] LIU Z,JIN H,YANG S,et al.SDC1 knockdown induces epithelial-mesenchymal transition and invasion of gallbladder cancer cells via the ERK/Snail pathway[J].J Int Med Res,2020,48(8):883-895.
[19] CHEN Y,QIN C,CUI X,et al.miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2[J].J Cell Physiol,2020,235(7-8):5711-5721.
[20] MELLEBY AO,STRAND ME,ROMAINE A,et al.The heparan sulfate proteoglycan Glypican-6 is upregulated in the failing heart,and regulates cardiomyocyte growth through ERK1/2 signaling[J].PLoS One,2016,11(10):79-90.